ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroC

GlobeNewswireApr 25 20:00

ProPhase Labs Shares Jump on New AI-Based Project

By Dean Seal Shares of ProPhase Labs jumped after the biopharma and diagnostics company unveiled a new project that utilizes an artificial-intelligence platform and its massive genomics database. Th

WSJApr 17 03:46

ProPhase Labs Unveils Project ZenQ-AI; Leveraging ProPhase Labs' AI Platform, Massive Genomics Database And Patented Esophageal Cancer Insights For Antibody Drug Conjugates Development

Leveraging ProPhase Labs' AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development.Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE) -- Pr

BenzingaApr 16 20:15

ProPhase Labs Unveils Project ZenQ-AI

Leveraging ProPhase Labs' AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE) --

GlobeNewswireApr 16 20:00

ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management With Launch of Its BE-Smart Test in H2 2024

Garden City, NY, April 10, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics, and diagnostics company, today reported its progress on the

GlobeNewswireApr 10 20:00

ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Garden City, NY, April 01, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biopharma, genomics, and diagnostics company, today announced that it has granted

GlobeNewswireApr 2 09:00